Home | UAC | Reference | Site Map | Contact Us |

Idaho Medicaid Pharmacy Program

Drug Utilization Review

Drug Utilization Review

Upcoming Meetings

July 15, 2021
October 21, 2021

Meeting Scheduled at 9am at IDHW Offices; 3232 Elder Street, Boise, Idaho 83705 (Meeting being held remotely)

Meeting Materials

Meeting Date Agenda Presentation Minutes
Meeting Date Agenda Presentation Minutes
April 15, 2021 Agenda Presentation Minutes
October 15, 2020 Agenda Presentation Minutes
April 16, 2020 Agenda Presentation Minutes
January 16, 2020 Agenda Presentation Minutes
October 17, 2019 Agenda Presentation Minutes
July 18, 2019 Agenda Presentation Minutes
April 18, 2019 Agenda Presentation Minutes
January 17, 2019 Agenda Presentation Minutes
November 15, 2018 Agenda Presentation Minutes
July 19, 2018 Agenda Presentation Minutes
January 25, 2018 Agenda Presentation Minutes
October 19, 2017 Agenda Presentation Minutes
July 20, 2017 Agenda Presentation Minutes
April 20, 2017 Agenda Presentation Minutes
February 16, 2017 Agenda Presentation Minutes
October 20, 2016 Agenda Presentation Minutes
July 21, 2016 Agenda Presentation Minutes
April 14, 2016 Agenda Presentation Minutes
January 21, 2016 Agenda Presentation Minutes
October 15, 2015 Agenda Presentation Minutes
July 16, 2015 Agenda Presentation Minutes
April 16, 2015 Agenda Presentation Minutes
January 15, 2015 Agenda Presentation Minutes
October 16, 2014 Agenda Presentation Minutes
April 17, 2014 Agenda Presentation Minutes
January 16, 2014 Agenda Presentation Minutes
October 10, 2013 Agenda Presentation Minutes
July 18, 2013 Agenda Presentation Minutes
April 18, 2013 Agenda Presentation Minutes
January 17, 2013 Agenda Presentation Minutes
October 18, 2012 Agenda Presentation Minutes
August 23, 2012 Agenda Presentation Minutes
April 19, 2012 Agenda Presentation Minutes
January 19, 2012 Agenda Presentation Minutes
October 20, 2011 Agenda Presentation Minutes
July 21, 2011 Agenda Presentation Minutes
April 14, 2011 Agenda Presentation Minutes
January 20, 2011 Agenda Presentation Minutes
October 21, 2010 Agenda Presentation Minutes
July 15, 2010 Agenda Presentation Minutes
May 20, 2010 Agenda Presentation Minutes

Newsletters

Title
Title
Idaho DUR Quarterly Newsletter - Volume 4, Number 1 - May 2014
Idaho DUR Quarterly Newsletter - Volume 3, Number 3 - September 2013
Idaho DUR Quarterly Newsletter - Volume 3, Number 2 - May 2013
Idaho DUR Quarterly Newsletter - Volume 3, Number 1 - February 2013
Idaho DUR Quarterly Newsletter - Volume 2, Number 4 - November 2012
Idaho DUR Quarterly Newsletter - Volume 2, Number 3 - September 2012
Idaho DUR Quarterly Newsletter - Volume 2, Number 2 - May 2012
Idaho DUR Quarterly Newsletter - Volume 2, Number 1 - February 2012
Idaho DUR Quarterly Newsletter - Volume 1, Number 4 - December 2011
Idaho DUR Quarterly Newsletter - Volume 1, Number 3 - September 2011
Idaho DUR Quarterly Newsletter - Volume 1, Number 2 - June 2011
Idaho DUR Quarterly Newsletter - Volume 1, Number 1 - February 2011

Outreach Materials

Date Title
Date Title
10/2015 Magellan Clinical Alert - October 2015
10/2015 Magellan Clinical Alert - September 2015
10/2015 Magellan Clinical Alert - August 2015
10/2015 Magellan Quarterly Trend Advisory - Volume 2, Issue 3
08/2015 Magellan Clinical Alert - July 2015
08/2015 Magellan Clinical Alert - June 2015
08/2015 Magellan Clinical Alert - May 2015
08/2015 Magellan Quarterly Trend Advisory - Volume 2, Issue 2
04/2015 Magellan Clinical Alert - April 2015
03/2015 Magellan Clinical Alert - March 2015
02/2015 Magellan Clinical Alert - February 2015
02/2015 Magellan Quarterly Trend Advisory - Volume 2, Issue 1
01/2015 Magellan Clinical Alert - January 2015
02/2013 Atopic Dermatitis
04/2012 FDA Drug Safety Communication: New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)
04/2012 FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury
02/2012 Transdermal Testosterone
04/2011 Risks Associated with Long Term Proton Pump Inhibitor Use
02/2011 FDA Drug Safety Communication: Avandia (rosiglitazone) labels now contain updated information about cardiovascular risks and use in certain patients
02/2011 Serotonin Syndrome